倍他乐克对老年慢性心力衰竭及血清 IL-12与BNP 水平的影响

Influence of metoprolol on elderly patients with chronic heart failure and serum IL-12 and BNP levels

  • 摘要: 目的:探讨倍他乐克辅助治疗老年慢性心力衰竭(CHF)的疗效,及其对血清白细胞介素12(IL-12)与脑尿钠肽(BNP)水平的影响。方法选择86例老年 CHF 患者为研究对象,随机将其分为观察组和对照组,每组43例。对照组患者采用常规药物进行,观察组在此基础之上联合应用倍他乐克治疗12周,观察临床疗效和血清 IL-12与 BNP 的变化。结果观察组总有效率为93.02%,显著高于对照组(P <0.01);2组患者治疗后血压、心率、LVEF 较治疗前均有显著改善(P <0.01),组间比较有显著差异(P <0.01);2组患者治疗后血清 BNP 和 IL-12水平均显著低于治疗前(P <0.01);组间比较有显著差异(P <0.01)。结论基础治疗联合应用倍他乐克治疗老年CHF的临床疗效优于单用基础治疗,可以更有效地调节血清中IL-12和 BNP 的表达,改善机体内环境。

     

    Abstract: Objective To explore the clinical efficacy of metoprolol on elderly patients with chronic heart failure (CHF)and its influence on serum interleukin-12 (IL-12)and brain natriuretic peptide (BNP)levels.Methods A total of 86 patients with CHF served as study objects and ran-domly divided into observation group and control group,43 cases for each.Routine medicines were given to control group while observational group added with metoprolol for 12 weeks.Clinical effica-cy and changes of serum IL-12 and BNP levels were observed.Results Total response rate in obser-vation group was 93.02%,evidently higher than in control group (P <0.01),and there were sig-nificant differences before and after treatment and between two groups in blood pressure,heart rate and left ventricular ejection fraction (LVEF)(P <0.01).Conclusion Basic therapies concomitant with metoprolol have better clinical efficacy than single application of basic therapies,and can more effectively regulate serum IL-12 and BNP expressions and improve the internal environment of body of elderly patients with CHF.

     

/

返回文章
返回